Skip to content

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants: A Prospective Medium Term Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05500755
Enrollment
150
Registered
2022-08-15
Start date
2022-07-29
Completion date
2026-12-31
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implants

Keywords

Dental implant, Complication, DS Prime Taper

Brief summary

The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a real analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.

Detailed description

The DS PrimeTaper implant has macro-design features that differ from its predecessor, the OsseoSpeed EV implant (AstraTech Implant System EV, Dentsply Implants, Mölndal, Sweden) with which they share a common surface and internal connection. Its macro-design has been modified through the introduction of variable thread forms and a more pronounced taper, ultimately making it more aggressive in terms of cutting ability. While its predecessor, the OsseoSpeed EV implant, has sufficient scientific support, this new system recently introduced on the market does not. All the scientific contributions that can be made will therefore be a first guide for the clinician who wishes to start using this dental implant system.

Interventions

DEVICEImplant Treatment

Surgical placement of a DS Prime Taper implant and its posterior prosthesis.

Sponsors

Aula Dental Avanzada
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years

Inclusion criteria

* All the patients whom received at least one DS Prime Taper implant.

Exclusion criteria

* When dental implant surgery is contraindicated.

Design outcomes

Primary

MeasureTime frameDescription
Implant Survival Ratethrough study completion, an average of 1 yearTime of survival of DS Prime Taper dental implant placed
Implant Success Ratethrough study completion, an average of 1 yearRadiological assessment of Marginal Bone Levels around DS Prime Taper implants in function
Biological and mechanical complications eventsthrough study completion, an average of 1 yearAll type of complications that may occur during implant survival

Countries

Spain

Contacts

Primary ContactGuillem Esteve-Pardo, PhD
guillem@clinicaesteve.com+34965215755

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026